Editas Medicine Competitors and Similar CompaniesClear all
Amyris's competitors and similar companies include Caribou Biosciences and Nuclera.
 Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. |  Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | ||
Founding Date | Founding Date 2003 | Founding Date 2012 | Founding Date 2013 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Emeryville, US HQ Sao Paulo, BR | Locations Berkeley, US HQ | Locations Cambridge, GB HQ |
Employees | Employees 1,0031% decrease | Employees 1477% decrease | Employees 1192% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $269.8m (FY, 2022) | Revenue (est.) $11.2m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($543.4m) (FY, 2022) | Net income ($148.1m) (FY, 2025) | Net income N/A |
Funding | |||
Latest funding round | Latest funding round $ 34m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 10m (over 7 years ago) |
Total funding raised | Total funding raised $ 551.9m | Total funding raised $ 159.5m | Total funding raised $ 11.3m |
For sources of this data, please see the company profile
View Company Profiles
Caribou Biosciences
HQ
Berkeley, US
Employees
147↓ 7% decrease
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company
Nuclera
HQ
Cambridge, GB
Employees
119↓ 2% decrease
Nuclera is a company that specializes in DNA synthesis.
View company